FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.7120
-0.0235 (-3.20%)
At close: Jul 24, 2026, 4:00 PM EDT
0.7450
+0.0330 (4.63%)
After-hours: Jul 24, 2026, 7:45 PM EDT
FibroBiologics Employees
FibroBiologics had 15 employees as of December 31, 2025. The number of employees increased by 2 or 15.38% compared to the previous year.
Employees
15
Change (1Y)
2
Growth (1Y)
15.38%
Revenue / Employee
n/a
Profits / Employee
-$1,245,333
Market Cap
3.84M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 15 | 2 | 15.38% |
| Dec 31, 2024 | 13 | 3 | 30.00% |
| Dec 31, 2023 | 10 | 3 | 42.86% |
| Sep 30, 2023 | 8 | 1 | 14.29% |
| Jun 30, 2023 | 7 | - | - |
| Dec 31, 2022 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 35 |
| PMGC Holdings | 34 |
| Genprex | 13 |
| Ensysce Biosciences | 10 |
| Revelation Biosciences | 9 |
| Artelo Biosciences | 7 |
| Galmed Pharmaceuticals | 6 |
| Mustang Bio | 4 |
FBLG News
- 8 days ago - FibroBiologics Proxy statement: Proxy filing - Filings
- 15 days ago - FibroBiologics Registration statement: Registration filing - Filings
- 15 days ago - FibroBiologics files to sell up to 12.53M shares of common stock - TheFly
- 16 days ago - FibroBiologics appoints Rubins to its Board of Directors - TheFly
- 16 days ago - FibroBiologics Appoints Kathleen "Kate" Rubins, Ph.D. to Board of Directors - PRNewsWire
- 18 days ago - FibroBiologics completes manufacturing of third batch of CYWC628 - TheFly
- 18 days ago - FibroBiologics Completes Manufacturing of Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial - PRNewsWire
- 25 days ago - FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference - PRNewsWire